The precise genetic mechanism of malignant transformation in DNA mismatch repair deficient, microsatelliteunstable colorectal cancer (CRC) has yet to be elucidated. We employed cDNA microarray to identify patterns of gene expression among CRC cell lines and to compare directly lines with and without microsatellite instability. This study was undertaken to test the hypothesis that microsatellite-unstable CRC cell lines demonstrate specific patterns of gene expression that differ significantly from those observed among microsatellite-stable CRC. Multiple differential expression patterns were identified. Genes demonstrating differential expression included deleted-in-oral-cancer-1 (DOC-1), a highly conserved growth suppressor. DOC-1 expression correlated with microsatellite status, with significantly decreased expression in microsatellite-unstable cell lines and constitutive expression in microsatellite-stable cell lines. We also observed alterations in the biologic behavior of p12 DOC-1 -deficient cell lines, with increased S phase and decreased apoptosis compared to microsatellite-stable (DOC-1 þ ) cell lines. Transfection of p12 DOC-1 into SW48, which lacks p12 DOC-1 expression, resulted in cell cycle and apoptosis profiles similar to other p12 DOC-1 þ cell lines. These results support the hypothesis that microsatellite-unstable CRC is characterized by novel patterns of gene expression different from those associated with microsatellite-stable CRC, and demonstrate that p12 DOC-1 has tumor suppressor potential in colon epithelial cells.
Introduction
Germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, or hMSH6, result in compromised function of the DNA mismatch repair (MMR) system (Kinzler and Vogelstein, 1996; Peltomaki and Vasen, 1997) , and are associated with a significantly increased risk of invasive colorectal cancer (CRC) among carriers. Over 80% of CRCs obtained from such carriers are characterized by alterations in the length of simple DNA repeat sequences known as microsatellite DNA (Kinzler and Vogelstein, 1996) . These characteristic alterations are referred to as microsatellite instability (Boland, 1997) . In all, 20% of 'sporadic' CRCs derived from individuals without family history of the disease also demonstrate microsatellite instability (Rodriguez-Bigas et al., 1997; Lynch and de la Chapelle, 1999) . MMR-associated microsatellite-unstable (MSI þ ) CRC represents a pathway of malignant transformation and progression distinct from sporadic microsatellite-stable (MSS) CRC (Rodriguez-Bigas et al., 1997) . This view is supported by cytologic observations characterizing the majority of MSI þ CRC as diploid with decreased loss of heterozygosity (LOH) compared to MSS tumors that are more likely to be aneuploid and demonstrate LOH (Rodriguez-Bigas et al., 1997) . A genomic level distinction between MSI þ and MSS CRC is further supported by reports demonstrating mutations (in MSI þ CRC) in growth-regulatory genes, including TGF-bRII, insulinlike growth factor, BAX, hMSH3, and hMSH6 (Boland et al., 1998; Markowitz, 2000) .
The presence of thousands of altered microsatellites in MMR-deficient CRC has been designated a 'mutator phenotype' (Loeb, 1999) with many authors suggesting that the large number and wide genomic distribution of altered microsatellites affect many growth-regulatory elements in addition to those noted above. According to this hypothesis, these widespread alterations ultimately facilitate malignant transformation (Boland et al., 1998) . The identification of those elements and their relation to cell growth regulation is required to elucidate unique transformation pathways for MSI þ CRC. cDNA microarray is a high-throughput differential gene expression technology that is a powerful analytic tool for the simultaneous evaluation of the expression of thousands of genes in samples from tissue or cell lines (He and Friend, 2001) . The applicability of cDNA microarray to the study of CRC has been demonstrated in the literature (Hegde et al., 2001; Notterman et al., 2001; Takemasa et al., 2001) , and it is therefore well suited for a comparative study of MSI þ vs MSS CRC differential gene expression.
Previous studies have used cell lines derived from sporadic colon tumors as in vitro models of the MSI þ phenotype (Cahill et al., 1998) . In this report, we present a comparison of gene expression between MSI þ and MSS CRC cell lines utilizing a DNA array-based strategy. Differential expression of 218 genes was demonstrated; we selected for further study of genetic elements associated with the TGF-b pathway as it plays a crucial role in cell cycle regulation and is altered in many MSI þ CRCs (Fishel, 1998; Markowitz, 2000) . Specifically, we report the novel observation of differential expression of the growth suppressor, deleted-inoral-cancer-1 (DOC-1), which has not previously been reported in relation to CRC. DOC-1 is a highly conserved gene mapped to chromosome 12q24. It was identified and characterized by LOH and decreased expression of its translation product, p12 , in oral squamous cell carcinoma (Todd et al., 1995; Tsuji et al., 1998) . p12 DOC-1 is constitutively expressed in normal human tissues and interacts with multiple cellular growth regulatory elements. Human p12 DOC-1 interacts with DNA polymerase alpha/primase resulting in negative regulation of the rate of initiation of DNA replication (Tsuji et al., 1998; Matsuo et al., 2000) . p12
DOC-1 also associates with the non-phosphorylated form of CDK2 . Shintani et al. (2000) reported that ectopic expression of p12 DOC-1 in human 293 cells was associated with decreased cellular CDK2-associated kinase activity and resulted in a decrease in S phase fraction. Recent work performed utilizing human keratinocytes suggests that p12 mediates TGF-b1 antiproliferation activity by suppressing CDK2-mediated phosphorylation of RB (Hu and Wong, 2002) . Each of these observations is consistent with a growth suppressor role for p12 . Decreased p12 DOC-1 expression has been shown to correlate with increased tumor invasion, risk of lymph node metastases, and decreased survival in patients with oral squamous cell carcinoma (Shintani et al., 2001) .
In our present study, we present a novel analysis of differential p12 DOC-1 expression in MSI þ vs MSS human CRC in which significant differences in p12 DOC-1 expression correlated with MSI status. This suggests that loss of p12 DOC-1 expression is a characteristic feature of malignant transformation and progression in MSI þ CRC. Clarification of transformation pathways unique to MSI þ CRC will facilitate the development of novel chemoprevention and therapeutic strategies for this CRC phenotype.
Results
Based on microsatellite instability in at least two of four designated markers and/or TGF-bR2 mutation (Boland et al., 1998) , the following cell lines were characterized as MSI(H) þ : HCT116, SW48, LoVo, and DLD-1. SW480, SW620, and CaCo2 were characterized as MSS. By Western blot analysis, hMLH1 protein was not expressed in HCT116 and SW48. hMSH2 protein was absent in LoVo and DLD-1. Both proteins were expressed in SW480, SW620, and CaCo2. Bax protein was expressed in all cell lines except Lovo. See Table 1 and Figure 1 for cell line characteristics. cDNA microarray was performed as described below, comparing MSI þ CRC cell lines, HCT116, SW48, and DLD-1, to SW480, which served as a reference. We identified 218 genes, including 20 expressed sequence tags (ESTs), with significant differential expression in at least five of six experiments. The structure and function of these genes fall into the following categories: DNA repair, TGF-b/SMADs, apoptosis, and proliferation (see Figure 2 ). From these groups of genes, we selected several of interest for further study. In this report, we focus on a previously described growth suppressor, DOC-1 (Todd et al., 1995) . We found DOC-1 to be significantly downregulated in the MSI þ cell lines, HCT116, SW48, and DLD-1, compared to SW480 (Expression ratios ¼ 0.52 and 0.5 (HCT116), 0.44 and 0.5 (SW48), 0.58 (DLD-1)).
Microarray results were confirmed and expanded by Northern and Western blot analysis. mRNA was probed for a-32 P-dCTP-labeled DOC-1. DOC-1 mRNA was DOC-1 in microsatellite-unstable colorectal cancer ZQ Yuan et al detected in normal colon and in MSS cell lines, SW480 and SW620, but was decreased or absent in the remaining MSI(H) þ cell lines (HCT116, SW48, LoVo, DLD-1) (see Figure 3) . HCT116, SW48, LoVo, DLD-1, SW480, SW620, and CaCo2 proteins were probed for DOC-1 using the FLAG-p12 DOC-1 antibody. A 12 kDa signal consistent with DOC-1 was present in the normal colon and in the MSS cell lines, SW480, SW620, and CaCo2, but was not detectable in the MSI þ cell lines (HCT116, SW48, LoVo, DLD-1) (see Figure 4) .
Flow cytometry (FACS) was employed to analyse the cell cycle and apoptosis profiles of selected cell lines. The w 2 -test was used to analyse the differences in proportion of S phase and apoptotic cells among MSI þ and MSS cell lines. The S phase cell population was significantly increased in the MSI þ cell lines, whereas the percentage of apoptotic cells was significantly lower, compared to the MSS cell lines. See Figure 5 . Nuclear fragmentation, also indicative of apoptosis, was evident to a greater extent in SW480 (MSS) compared to SW48 (MSI þ ) by TUNEL assay (see Figure 6 ).
To determine whether p12 DOC-1 expression contributes to cell proliferative activity and apoptosis profile, p12 DOC-1 expression was induced in SW48, an MSI þ cell line lacking constitutive p12 DOC-1 expression. Protein expression was determined at 16, and 32 h posttransfection by Western Blot analysis (see Figure 7) . FACS analysis of the induced p12 DOC-1 SW48 demonstrated cell cycle and apoptosis profiles resembling those of the MSS cell lines with constitutive p12 DOC-1 expression. At 16 and 32 h post-transfection, the apoptotic cell percentage increased and the S phase population decreased significantly (Po0.001), in comparison to SW48 transfected with empty vector (see Table 2 ).
Discussion

MMR-deficient MSI
þ CRC is initiated and progresses via pathways that are different than those of MSS CRC (Peltomaki and Vasen, 1997; Martin et al., 1999; Barnetson et al., 2000; Gryfe et al., 2000) . Many authors agree that this hypothesis requires continued study to define the precise targets of the genomic instability (Kinzler and Vogelstein, 1996; Loeb, 1999) Of the approximately 9000 genes spotted onto our slides for hybridization and comparative analysis, we focused our attention on those that were significantly differentially expressed in at least five of six cell lines (Figure 2) . We selected for further study genetic elements associated with the TGF-b pathway as it plays a crucial role in cell cycle regulation and is altered in many MSI þ CRCs (Fishel, 1998; Markowitz, 2000 DOC-1 expression as measured by microarray (HCT116, SW48) or Northern and Western blots (HCT116, SW48, LoVo, DLD-1). We are unaware of any prior reports addressing DOC-1 expression in CRC.
Previous reports have indicated that p12 DOC-1 expression is significantly reduced or absent among human oral squamous cell carcinoma. In 2000, Shintani et al. (2001) reported no tumor tissues or transformed cell lines, of 35 examined, were found to express p12 . In a subsequent study, the same investigators reported reduction or absence of p12 DOC-1 expression among 81 cases of human oral squamous cell carcinoma, representing 64% of the total studied (Shintani et al., 2001) . In contrast, all MSS CRC cell lines studied demonstrated p12 DOC-1 expression as measured by microarray, Northern, and/or Western blots. Most importantly, the differential expression of p12 DOC-1 we observed correlated precisely with microsatellite status. This finding supports the hypothesis that MSI þ CRC is characterized by specific gene expression profiles differing from those associated with MSS CRC.
In order to investigate the association between p12 DOC-1 expression and cell growth in human CRC, we employed flow cytometry analysis. We observed a significant increase in S phase fraction among the MSI þ lines tested compared to the MSS control. This finding is consistent with previous reports indicating that p12 associates with the non-phosphorylated form of CDK2 in human 293 cells , preventing the conformational changes that allow cyclin binding, phosphorylation, CDK2 activation, and cell cycle progression (Morgan, 1995; Matsuo et al., 2000) . These results suggest that in MSI þ CRC, absent DOC-1 expression facilitates increased S phase fraction and cell growth. It also provides further evidence of different cell growth characteristics between MSI þ and MSS CRC. FACS analysis also demonstrated a significant decrease in apoptotic activity among the MSI þ cell lines, HCT116, SW48, and DLD-1, compared to the MSS cell lines, SW480 and SW620, in the setting of consistent Bax protein expression. These data were supported by TUNEL nuclear fragmentation analysis, which also demonstrated decreased apoptosis in MSI þ SW48, compared to MSS SW480. These findings also suggest that differences in growth (S phase) and growth regulation (apoptosis) are measurable and correlate with MSI status.
In order to further assess the role of DOC-1 expression in the regulation of cell cycle progression and apoptosis in CRC, we induced p12 DOC-1 expression in an MSI þ line (SW48) lacking constitutive expression. Subsequent FACS analysis indicated a reduction in S phase fraction following induction of p12 DOC-1 expression. The cell cycle profile of SW48, post-p12 DOC-1 induction, was very similar to that observed among our control line which constitutively expressed DOC-1 (SW480). These results suggest that variable DOC-1 expression contributes to altered cell cycle kinetics in human CRC, and also indirectly supports the DOC-1/ CDK2 interaction reported by Shintani et al. (2000 Shintani et al. ( , 2001 . We reassessed apoptotic activity in the SW48 line post-p12 DOC-1 induction and observed an increase in apoptosis by FACS. The post-p12 DOC-1 apoptotic pattern was again similar to that observed for the MSS control line SW480 which constitutively expresses DOC-1. Moreover, the apoptosis profile was p12 DOC-1 dosedependent (see Figure 7) . Although DOC-1 and apoptosis have been found to be associated in hamster models of oral squamous cell carcinoma (Cwikla et al., 2000; Kohno et al., 2002) , our finding is of interest as we are unaware of any prior report linking DOC-1 expression to the regulation of apoptosis in CRC.
We acknowledge that our present work does not explain the basis for the observed association between MSI þ status and decreased DOC-1 expression. We sequenced the cDNA of DOC-1 in HCT116, SW48, LoVo, and DLD-1, but found no evidence of simple repeat sequences that might be affected by compromised mismatch repair. Our planned investigations include demonstration of the reproducibility of our p12 DOC-1 cell line findings in ex vivo MSI þ and MSS human CRC. We also plan further analysis of the role of DOC-1 differential expression in the regulation of apoptosis and additional characterization of the differentially expressed genes identified in our current microarray expression analysis.
We believe our observation of p12 DOC-1 differential expression in human CRC is noteworthy given its established role in growth control, cell cycle kinetics, and DNA replication (Tsuji et al., 1998; Matsuo et al., 2000; Shintani et al., 2000; Hu and Wong, 2002) . The observed close correlation of DOC-1 expression with MSI status is consistent with the hypothesis that MSI þ CRCs are characterized by gene expression that differs and MSS CRC malignant transformation. Such studies will contribute to our understanding of already described differences in natural history between MSI þ and MSS CRC, and assist efforts to develop novel prevention and treatment strategies.
Materials and methods
Cell lines
CRC cell lines, HCT116, SW48, LoVo, DLD-1, SW480, SW620 (metastatic tumor, same patient as SW480), and CaCo2, were kindly provided by Dr. Leonard Augenlicht (Albert Einstein College of Medicine (AECOM) (2002), NY, USA). Cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) with l-glutamine supplemented with 10% fetal bovine serum, 50 U/ml streptomycin-penicillin, 1% nonessential amino acid and HPEBS. They were incubated at 371C with 5% CO 2 to 60-70% confluence. RNA, DNA, and protein from all cell lines were isolated with Trizol (Life Technologies, Carlsbad, CA, USA) according to kit instructions.
Determination of CRC phenotype in cell lines
Microsatellite instability and frameshift mutations in the coding regions of TGF-bRII were identified in the CRC cell lines by the presence of at least two of the standard MSI markers (BAT-25, BAT-26, BAT-40, D18S58) and/or a mutation in the TGF-aˆRII as previously described by NCI criteria, the Bethesda guidelines (Boland et al., 1998; Sepulveda et al., 1999) . We determined hMLH1, hMSH2, and Bax protein expression levels in our CRC cell lines using Western blot analysis. The Western blot was performed as described previously using hMLH1, hMSH2, and Bax mouse IgG antibody (Oncogene, San Diego, CA, USA) (Fink et al., 1997) .
cDNA Microarray analysis
Total RNA was extracted from MSI þ CRC cell lines, HCT-116, SW48, DLD-1, as well as from the MSS cell line, SW480, as described above. Total RNA (100 mg) was used to produce labeled cDNA by anchored oligo (dT)-primer reverse transcription using SuperScript II reverse transcriptase (Life Technologies, Inc., Carlsbad, CA, USA) in the presence of fluorescent dye, Cy5-dUTP or Cy3-dUTP (Amersham, Piscataway, NJ, USA), respectively. The fluorescent cDNA probes were then hybridized to Silane glass slides with 9568 cDNA human gene spots according to AECOM standard protocol in which each slide was probed with one MSI þ cDNA probe and SW480 (Harris et al., 2000; AECOM website) . Slides were scanned in our microarray facility scanner, and the images were exported to GenePix Pro 3.0 software (Axon Instruments, Inc, Union City, CA, USA) for signal intensity analysis. Each experiment was repeated. Poor quality spots were flagged and excluded from analysis.
Statistical methods
Signal intensity information was exported to Excel. The data were normalized for statistical analysis. A Student's t-test was used to determine the significance of the difference in signal intensity of the spot compared to the background, with Po0.001. Data were sorted based on 'fold change', and genes with at least 1.5-fold change were accepted as significant based on the t-test criterion value, and chosen for further consideration.
Northern blot assay
Total RNA (10 mg) from each cell line and from normal human colon tissue (Clontech Inc., Palo Alto, CA, USA) were separated on a 1% agarose-formaldehyde gel and transferred to an N-Hybond membrane (Amersham, Piscataway, NJ, USA). The cDNA probe for the DOC-1 gene was labeled with a-32 P-dCTP by a random oligonucleotide priming labeling kit (Invitrogen, Carlsbad, CA, USA) and purified by QIAquick Nucleotide Removal Kit (Qiagen, Valencia, CA, USA). Hybridization was carried out with radiolabeled probes in hybridization buffer at 651C. Autoradiography was performed by exposing the blots at À701C.
Western blot assay
Whole-cell protein was extracted from cultured CRC cell lines (HCT116, SW48, LoVo, DLD-1, SW480, SW620, CaCo2) and subjected to Western Blot analysis with the FLAG-p12 DOC-1 polyclonal antibody (Wong, Boston, USA) as described by Shintani et al. (2000 Shintani et al. ( , 2001 . The membrane was incubated with the anti-p12 DOC-1 antibody at a dilution of 1 : 8000. Horseradish peroxidase-conjugated rabbit anti-mouse antibody was used as the secondary antibody, and was hybridized for 1 h at room temperature. Proteins were then detected by a Super Signal West Pico kit (Pierce, Rockford, IL, USA) and exposed to X-ray film.
FACS analysis of cell cycle and apoptosis
MSI
þ and MSS CRC cell lines: HCT116, SW48, DLD-1, SW480, and SW620, were put into suspension and centrifuged. Pellets were washed and resuspended in 50 ml of cold PBS and 450 ml of cold methanol for 1h at 41C. The cells were centrifuged for 5 min, the pellets washed, resuspended in PBS, and incubated with RNase at 371C for 30 min. The cells were chilled over ice for 10 min and stained with propidium iodide for 30 min at room temperature in darkness and cell cycles were analysed by flow cytometry using the FACScan (Becton-Dickinson, Lexington, KY, USA). Apoptosis was quantified by FACS.
TUNEL assay
The ApoAlter DNA Fragmentation assay Kit (Clontech, Palo Alto, CA, USA) was used to detect apoptosis in SW48 and SW480. These cell lines were cultured on Lab-Tek chamber slides (Myriad, San Diego, CA, USA) prior to washing and fixing with fresh 4% formaldehyde/PBS for 25 min at 41C. After two washings, the slides were immersed in 0.2% Triton X-100/PBS for 5 min on ice, and then washed with PBS. Cells were then immersed in 100 ml of equilibration buffer for 10 min at room temperature, and then cultured with 50 ml of TdT incubation buffer in a dark, humidified 371C incubator for 60 min. The reaction was terminated by immersion in 2 Â SSC for 15 min. The sealed slides were then viewed under fluorescence microscopy for detection of nuclear fragmentation, indicating apoptosis.
Transient transfection with endogenous p12
DOC-1 p12 DOC-1 was transfected into SW48 using an empty vector (pcDNA 3 ), or 1 or 5 mg of p12 -CMV expression plasmid (from Wong, Boston, USA) according to the DOTAP Liposomales Transfetionsreagenz Kit (Roche, Inc., Switzerland). Cells were incubated and harvested at 16 and 32 h posttransfection for detection of p12 DOC-1 protein expression. Cell cycle and apoptosis analyses with FACS were repeated for the altered SW48 cell line, as described above.
